The E3 ubiquitin ligase seven in absentia homolog 1 may be a potential new therapeutic target for Parkinson′s disease

The E3 ubiquitin ligase seven in absentia homolog 1 may be a potential new therapeutic target for Parkinson′s disease

In this study, we investigated the effect of an antibody against E3 ubiquitin ligase seven in absentia homolog 1 (SIAH-1) in PC12 cells. 1-Methyl-4-phenylpyridinium (MPP + ) treatment increased α-synuclein, E1 and SIAH-1 protein levels in PC12 cells, and it reduced cell viability; however, there was...

Full description

Bibliographic Details
Main Authors: Zeng-lin Cai, Jing Xu, Shou-ru Xue, Yuan-yuan Liu, Yong-jin Zhang, Xin-zhi Zhang, Xuan Wang, Fang-ping Wu, Xiao-min Li
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Neural Regeneration Research
Subjects:
nerve regeneration; neurodegeneration; Parkinson′s disease; ubiquitin-proteasome system; autophagy; E3 ubiquitin ligase seven in absentia homolog 1; 1-methyl-4-phenylpyridinium; rapamycin; neural regeneration
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=8;spage=1286;epage=1291;aulast=Cai

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=8;spage=1286;epage=1291;aulast=Cai

Similar Items